Vivo Ventures Fund VI, L.P.
Related Filers (7)
- Sagent Pharmaceuticals, Inc. (3)
- Carbylan Therapeutics, Inc. (2)
- Eiger BioPharmaceuticals, Inc. (2)
- AVANIR PHARMACEUTICALS, INC. (1)
- DYNAVAX TECHNOLOGIES CORP (1)
- Vivo Ventures VI, LLC (1)
- VIVO VENTURES VI AFFIILATES FUND, L.P. (1)
- Show More ...
Ownership (18)
4
Thursday, 9/1/2016
Sagent Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 8/22/2016
Eiger BioPharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/25/2016
Sagent Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 3/28/2016
Eiger BioPharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 11/4/2015
Sagent Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4/A
Friday, 4/24/2015
Carbylan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/14/2015
Carbylan Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 4/8/2015
Carbylan Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 9/17/2013
Sagent Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/13/2012
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
3
Tuesday, 4/19/2011
Sagent Holding Co.: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 2/14/2011
AVANIR PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Friday, 4/23/2010
DYNAVAX TECHNOLOGIES CORP: Major Shareholders
SC 13G/A
Friday, 2/12/2010
AVANIR PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Tuesday, 8/18/2009
AVANIR PHARMACEUTICALS, INC.: Major Shareholders
4
Thursday, 8/13/2009
AVANIR PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 8/3/2009
AVANIR PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
4
Monday, 8/3/2009
AVANIR PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities